Valeant Announces Third-Quarter 2017 Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. CVS
10. SPY

Go back to Valeant Announces Third-Quarter 2017 Results

Valeant Pharma (VRX) Trades Near High, Up 18%

November 7, 2017 9:44 AM EST

Valeant Pharma (NYSE: VRX) Trades Near High, Up 18%

... More

Valeant Pharma (VRX) Reports Q3 EPS of $3.69, Beating Views

November 7, 2017 7:10 AM EST

Valeant Pharma (NYSE: VRX) reported Q3 GAAP EPS of $3.69, versus ($3.49) last year. Revenue for the quarter came in at $2.22 billion, versus $2.48 billion reported last year and the consensus of $2.165 billion. Adjusted EBITDA (non-GAAP) of $951 million, versus the consensus of $872 million and adjusted Net Income of $367 million versus the consensus of $311 million.

"Our strong third-quarter performance... More